67 results
Page 3 of 4
8-K
EX-99.1
evnb6rx5or68s zzmvf
10 May 18
Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
4:56pm
424B5
30vfl vbo
4 Feb 15
Prospectus supplement for primary offering
12:00am
8-K
cxpjc07t8xxgg9rneha
2 Feb 15
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
12:00am
S-3ASR
69qh7a
2 Feb 15
Automatic shelf registration
12:00am
424B5
qz277qf3k7mny dufgcg
2 Feb 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
rjb2c75o4gr sbsh
3 Dec 14
ZIOPHARM and Intrexon Present Clinical and Preclinical Data from Immuno-Oncology Programs at AACR Tumor Immunology and Immunotherapy Meeting
12:00am